Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorLu, Yen\\-Shen
dc.contributor.authorMahidin, Eznal Izwadi Bin Mohd
dc.contributor.authorAzim, Hamdy
dc.contributor.authorEralp, Yesim
dc.contributor.authorYap, Yoon Sim
dc.contributor.authorIm, Seock\\-Ah
dc.contributor.authorRihani, Julie
dc.contributor.authorGokmen, Erhan
dc.contributor.authorEl Bastawisy, Ahmed
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorLim, Yueh Ni
dc.contributor.authorLim, Chun Sen
dc.contributor.authorDuc, Le Thanh
dc.contributor.authorChung, Wei\\-Pang
dc.contributor.authorBabu, K. Govind
dc.contributor.authorPenkov, Konstantin
dc.contributor.authorBowles, James
dc.contributor.authorAlfaro, Teresa Delgar
dc.contributor.authorWu, Jiwen
dc.contributor.authorGao, Melissa
dc.contributor.authorSlimane, Khemaies
dc.contributor.authorEl Saghir, Nagi S.
dc.date.accessioned2025-10-16T15:12:51Z
dc.date.issued2024
dc.identifier.doi10.1200/JCO.24.00144
dc.identifier.otherWOS:001293663100009
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5643
dc.publisherLIPPINCOTT WILLIAMS \& WILKINS
dc.sourceJOURNAL OF CLINICAL ONCOLOGY
dc.titleFinal Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS